Forbes: Paying People To Lower Their Cholesterol Works But Is It Cost-Effective?

“A study published in 2015 got a lot of fanfare because of its tantalizing conclusion: Providing financial incentives to people for lowering their LDL cholesterol levels made them more likely to adhere to statin regimens, which did, in fact, make them healthier. But was it cost effective, in light of the added expenses associated with providing such incentives?

A follow-up study published today in the journal JAMA Network Open set out to answer that question. The results are compelling, but they also bring up a fresh new set of questions.” Read more at Forbes